Skip to content
Home/Companies/Healthcare/Schülke

Schülke

Healthcare·Germany·Exited 2023·Held 3yr
Entry
2020
Hold
3yr
Exit
2023

Who owns Schülke?

Schülke was owned by EQT through EQT VIII (2018 vintage) from 2020 to 2023, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-18

EQT
Investor
EQT
EQT VIII · 2018 · Buyout

Key facts

HQGermany
SectorHealthcare
StatusAcquired
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2023

More from EQT VIII

Other portfolio companies in the same fund.

RIMES Technologies
Exited 2024
Data & AnalyticsUK· 2020
to
SHL Medical
Active
MedTechSwitzerland· 2020
Acumatica
Active
SaaSUS· 2019
Aldevron
Aldevron
Exited 2021
BiotechUS· 2019
to
AutoStore
Exited 2021
IndustrialsNorway· 2019
Dellner Couplers
Exited 2026
IndustrialsSweden· 2019
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Schülke

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Schülke?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Schülke.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue